Avidity Partners Management LP 13D and 13G filings for Viridian Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 12:19 pm Sale | 2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | Avidity Partners Management LP | 0 0.000% | -1,278,261 (Position Closed) | Filing |
| 2022-02-11 8:10 pm Purchase | 2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | Avidity Partners Management LP | 1,278,261 5.900% | 1,278,261 (New Position) | Filing |
| 2021-10-27 6:12 pm Purchase | 2021-10-21 | 13G | Viridian Therapeutics, Inc. VRDN | Avidity Partners Management LP | 1,120,925 6.600% | 1,120,925 (New Position) | Filing |